Literature DB >> 11488425

Adenosine, oxidative stress and cytoprotection.

V Ramkumar1, D M Hallam, Z Nie.   

Abstract

Adenosine, a metabolite of ATP, serves a number of important physiological roles in the body. These actions contribute to sedation, bradycardia, vasorelaxation, inhibition of lipolysis and regulation of the immune system and are mediated, in part, through activation of three distinct adenosine receptor (AR) subtypes. To date, four receptor types have been cloned: A1, A2A, A2B and A3. It is becoming increasing clear that adenosine contributes significantly to cytoprotection, a function mediated principally by the A1AR and A3AR. In this review, we survey the literature on the role of adenosine and the mechanisms underlying cytoprotection and ischemic preconditioning, a process characterized by cytoprotection derived from repeated brief ischemic challenges. An important recent observation is that the expression of several AR subtypes could be regulated by oxidative stress to provide a greater cytoprotective role. Thus, like other proteins known to be regulated during ischemia, the A1AR and A3AR can be considered as being inducible receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488425     DOI: 10.1254/jjp.86.265

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  22 in total

1.  Adenosine decreases oxidative stress and protects H2O2-treated neural stem cells against apoptosis through decreasing Mst1 expression.

Authors:  Masoumeh Gholinejad; Iraj Jafari Anarkooli; Amirhossein Taromchi; Alireza Abdanipour
Journal:  Biomed Rep       Date:  2018-03-27

2.  Pretreatment with adenosine and adenosine A1 receptor agonist protects against intestinal ischemia-reperfusion injury in rat.

Authors:  V Haktan Ozacmak; Hale Sayan
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 3.  Recent findings and emerging questions in cochlear noise injury.

Authors:  Kevin K Ohlemiller
Journal:  Hear Res       Date:  2008-08-29       Impact factor: 3.208

4.  Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.

Authors:  Sarvesh Jajoo; Debashree Mukherjea; Kounosuke Watabe; Vickram Ramkumar
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

5.  Interaction of exercise and adenosine receptor agonist and antagonist on rat heart antioxidant defense system.

Authors:  Kazim Husain; Satu M Somani
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

6.  [Functional significance of adenosine receptors in the eye and their dysregulation in pseudoexfoliation syndrome].

Authors:  U Schlötzer-Schrehardt; M Zenkel; C Hofmann-Rummelt; F E Kruse; G O Naumann
Journal:  Ophthalmologe       Date:  2005-11       Impact factor: 1.059

7.  Adenosine postconditioning protects against myocardial ischemia-reperfusion injury though modulate production of TNF-α and prevents activation of transcription factor NF-kappaB.

Authors:  Jian-Juan Ke; Feng-Xu Yu; Yan Rao; Yan-Lin Wang
Journal:  Mol Biol Rep       Date:  2010-04-09       Impact factor: 2.316

8.  A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.

Authors:  Bunyen Teng; Jonathan D Smith; Michael E Rosenfeld; Peggy Robinet; Mary E Davis; R Ray Morrison; S Jamal Mustafa
Journal:  Cardiovasc Res       Date:  2014-02-12       Impact factor: 10.787

9.  Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity.

Authors:  David Ribé; David Sawbridge; Sapna Thakur; Martin Hussey; Catherine Ledent; Ian Kitchen; Susanna Hourani; Jian-Mei Li
Journal:  Free Radic Biol Med       Date:  2008-01-05       Impact factor: 7.376

10.  Role of beta-arrestin1/ERK MAP kinase pathway in regulating adenosine A1 receptor desensitization and recovery.

Authors:  Sarvesh Jajoo; Debashree Mukherjea; Sunny Kumar; Sandeep Sheth; Tejbeer Kaur; Leonard P Rybak; Vickram Ramkumar
Journal:  Am J Physiol Cell Physiol       Date:  2009-10-14       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.